Pharmabiz

China NMPA grants breakthrough therapy designation to Kelun-Biotech’s sacituzumab tirumotecan in combo with immunotherapy pembrolizumab for first-line treatment of PD-L1 ...

China NMPA grants breakthrough therapy designation to Kelun-Biotech’s sacituzumab tirumotecan in combo with immunotherapy pembrolizumab for first-line treatment of PD-L1-positive NSCLC ...
Pharmabiz

MTaI seeks Centre to align medtech customs and GST structures with other priority sectors

MTaI seeks Centre to align medtech customs and GST structures with other priority sectors: Our Bureau, New Delhi Tuesday, January 6, 2026, 15:40 Hrs [IST] The Medical Technology A ...
Pharmabiz

Nethradhama with Karnataka and Bangalore Ophthalmology Societies to conduct Phaco Festival 2026 from Jan 16 to 18

Nethradhama with Karnataka and Bangalore Ophthalmology Societies to conduct Phaco Festival 2026 from Jan 16 to 18: Our Bureau, Bengaluru Tuesday, January 6, 2026, 13:45 Hrs [IST] ...
Pharmabiz

ScinoPharm receives US FDA approval for glatiramer acetate injection to treat multiple sclerosis

ScinoPharm receives US FDA approval for glatiramer acetate injection to treat multiple sclerosis: Taiwan Tuesday, January 6, 2026, 14:00 Hrs [IST] ScinoPharm Taiwan, a professiona ...
Pharmabiz

AIOCD urges PM to shut down illegal e-pharmacies amid rising antibiotic resistance

AIOCD urges PM to shut down illegal e-pharmacies amid rising antibiotic resistance: Peethaambaran Kunnathoor, Chennai Tuesday ...
Pharmabiz

CDSCO brings in guidelines and SOPs on compounding of offences

CDSCO brings in guidelines and SOPs on compounding of offences: Gireesh Babu, New Delhi Tuesday, January 6, 2026, 08:00 Hrs ...
Pharmabiz

Hutchmed begins phase III stage of the ongoing trial of the combination of surufatinib and camrelizumab to treat naïve pancreatic ductal adenocarcinoma

Hong Kong, Shanghai Tuesday, January 6, 2026, 13:00 Hrs [IST] ...
Pharmabiz

US FDA accepts for priority review for Sanofi’s sBLA for Tzield for young children with stage 2 type 1 diabetes

US FDA accepts for priority review for Sanofi’s sBLA for Tzield for young children with stage 2 type 1 diabetes: Paris Tuesday, January 6, 2026, 12:00 Hrs [IST] The US Food and ...
Pharmabiz

Insilico Medicine announces US$ 888 million multi-year collaboration with Servier for drug discovery and development in oncology

Insilico Medicine announces US$ 888 million multi-year collaboration with Servier for drug discovery and development in oncology: Cambridge, Massachusetts Tuesday, January 6, 2026 ...
Pharmabiz

China NMPA approves GSK’s Nucala to treat adults with chronic obstructive pulmonary disease

China NMPA approves GSK’s Nucala to treat adults with chronic obstructive pulmonary disease: London, UK Tuesday, January 6, 2026, 10:00 Hrs [IST] GSK plc announced that China’ ...
Pharmabiz

Indian pharma eyes promising prospects with needle-free drug delivery transforming patient safety & comfort

Indian pharma eyes promising prospects with needle-free drug delivery transforming patient safety & comfort: Nandita Vijayasimha, Bengaluru Tuesday, January 6, 2026, 09:00 Hrs [IS ...
Pharmabiz

AstraZeneca notes baxdrostat shows reduction in systolic blood pressure in phase III of uncontrolled or resistant hypertension

AstraZeneca notes baxdrostat shows reduction in systolic blood pressure in phase III of uncontrolled or resistant hypertension: Our Bureau, Bengaluru Monday, January 5, 2026, 18:0 ...